Nootropics Index - Save on smarter supplements
Nootropics>Botanical & herbal supplements>Senna
Botanical & herbal supplements

Senna

Senna leaf / sennosides (Senna alexandrina)

Senna is a stimulant laxative herb, not a nootropic. Its active sennosides are used in short-term constipation and bowel-emptying contexts; oral products commonly produce a bowel movement 6-12 hours later rather than an acute mental-performance effect. No reliable human evidence supports focus, memory, mood, or mental-energy benefits. For generally healthy adults using a labeled oral product short term, base risk is moderate because cramping and diarrhea can be dose-limiting and labels restrict self-use duration; prolonged or high-dose use, interactions, and pregnancy/lactation need separate caution.

Standardized ExtractTraditional UseLimited Human EvidenceDose Dependent EvidenceForm Dependent EvidenceModerate Risk ProfileGi Side Effects
Updated August 2026/7 min read/10 citations
Reviewed by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
01

What is it?

Senna is a laxative, not a cognitive supplement

9

Senna is a stimulant laxative, not a cognitive supplement. Current U.S. OTC sennosides labels address occasional constipation and short-term use. For comparisons, check each product label for sennosides and directions rather than inferring an active dose from package weight or marketing language.

No nootropic role is established8
No reliable human evidence shows that senna improves focus, memory, mood, or mental energy. The human evidence base concerns bowel movement and constipation outcomes, not mental performance. Detox, flat-stomach, weight-loss, and daily-wellness marketing do not create a nootropic benefit.

Where the evidence is strongest

8

Senna is a stimulant laxative. The 2023 AGA/ACG guideline conditionally suggests it for adults with chronic idiopathic constipation, but rates the evidence low certainty because it identified one small 4-week placebo-controlled trial, very limited short-term harms data, and no long-term human safety data. This is laxative evidence, not cognitive evidence.

02

Names, aliases and forms

Latin NameSenna alexandrina
Common NameAlexandrian senna
Plant Partssenna leaf; senna pod
Active Constituentssennosides; sennoside A
03

Mechanisms of action

Sennosides stimulate bowel activity after bacterial conversion

4

Sennosides are anthraquinone glycosides that are hydrolyzed by colonic bacteria. Their metabolites act locally in the colon, increasing peristalsis and fluid accumulation that can lead to a bowel movement hours later. This bowel-focused mechanism explains both laxative use and cramping or diarrhea risk; it does not imply a brain-enhancing mechanism.

04

Potential effects and evidence map

Senna has limited human evidence as a laxative and no reliable human evidence for cognitive enhancement. A 2023 AGA/ACG guideline conditionally suggests senna for adults with chronic idiopathic constipation, but rates the evidence as low certainty: its evidence review found one small 4-week placebo-controlled trial, limited short-term harms reporting, and no long-term human safety data. Base risk is moderate rather than low because cramping, abdominal discomfort, and diarrhea can be dose-limiting and OTC labels restrict unsupervised use to one week. High is not used for ordinary short-term oral use because LiverTox describes clinically apparent liver injury as rare and associated with high-dose or prolonged exposure; those circumstances remain targeted cautions.

Effect domainMagnitudeGrade
Focus / attention3
UnknownConfidence: High

Senna has no reliable human evidence for focus or attention benefits.

Note Its established effect is laxative, not cognitive.

0/5
D
Memory / learning5
UnknownConfidence: High

Senna has no direct human evidence for memory or learning benefits.

Note Do not reinterpret constipation evidence as nootropic evidence.

0/5
D
Mental energy / wakefulness3
UnknownConfidence: High

Senna should not be used for energy, wakefulness, detox, or weight-loss goals.

Note GI stimulation and fluid loss can impair wellbeing rather than improve mental energy.

0/5
D
05

Typical dosages and timing

Typical
8.6-17.2 mg/day
Not a recommendation
Lower bound
8.6 mg/day
Profile value
Upper bound
17.2 mg/day
Profile value
Guideline dose context88.6-17.2 mg/day

The 2023 AGA/ACG guideline table lists 8.6-17.2 mg/day as an adult senna dose context, while the evidence review notes that the trial used a higher amount and that rigorous dose-ranging data are unavailable. Leaf grams, pods, teas, powders, and extracts are not interchangeable unless the label discloses sennosides. This is a guideline dose context, not a way to infer active dose from an unstandardized offer.

06

Timing & effect horizon

Effect horizonUnknown
Unknown
Onset3Acute
6-12 hours
Effects are delayed and bowel-focused9

U.S. OTC labels commonly state a 6-12 hour bowel-movement timeline for oral sennosides and often suggest bedtime dosing. That delayed laxative timing is not an acute mental-performance effect.

07

Safety, side effects and risk profile

GI discomfort8
Confidence: Medium

Cramping, abdominal discomfort, nausea, and diarrhea can be dose-limiting with oral senna products.

Note This common practical burden makes low base risk insufficient, but it does not by itself justify high risk.

3/5
C
Interaction risk10
Confidence: Medium

Prolonged laxative use or diarrhea can aggravate electrolyte imbalance with some medicines.

Note For EMA-covered senna leaf medicines, cardiac glycosides, antiarrhythmics, QT-prolonging medicines, diuretics, corticosteroids, and liquorice root warrant medical review.

3/5
C
Liver / kidney caution4
Confidence: Medium

Rare clinically apparent liver injury is linked mainly to high-dose or prolonged senna exposure.

Note This is a targeted chronic-use caution, not a common harm from ordinary short-term labeled use.

2/5
C
Dependence / withdrawal risk10
Confidence: Medium

Frequent or prolonged stimulant-laxative use can lead to dependence and impaired bowel function.

Note The one-week OTC self-use limit and EMA short-term-use guidance keep this separate from the healthy-adult base risk.

2/5
C
Pregnancy / lactation caution10
Confidence: Medium

EMA-covered senna leaf preparations must not be used during pregnancy or breastfeeding, or by children under 12.

Note This EU monograph is product- and jurisdiction-specific; it is a targeted special-population caution.

3/5
C
Evidence uncertainty6
Confidence: High

Evidence supports laxative use, not cognitive enhancement, detoxification, or weight loss.

Note The nootropic uncertainty is high because the relevant human cognitive evidence is absent.

4/5
B
Duration limit9Clinician review if more than 1 week

A current U.S. OTC sennosides label says not to use laxative products for longer than one week unless directed by a doctor. That short self-use limit makes senna a poor fit for daily nootropic stacks or wellness routines.

Stop and reassess9

U.S. OTC labels say to seek medical advice for rectal bleeding or failure to have a bowel movement after laxative use. They also flag abdominal pain, nausea, vomiting, and a sustained bowel-habit change as reasons to check before use.

Liver caution4High-dose or prolonged exposure

LiverTox describes senna as a rare cause of clinically apparent liver injury, especially with high-dose or prolonged use. That does not mean normal short-term label use commonly injures the liver, but it does make chronic detox-style or escalating-dose use a poor risk tradeoff.

Jurisdiction-specific caution10

For the senna-leaf medicines covered by the EMA monograph, the preparations must not be taken during pregnancy or breastfeeding, or by children under 12. Product authorization, form, and labeling vary by market, so do not generalize this specific EU monograph to every product worldwide.

08

Interactions and cautions

Interaction caution10

For the senna-leaf preparations covered by its monograph, the EMA advises medical review before combining with cardiac glycosides, antiarrhythmics, QT-prolonging medicines, diuretics, corticosteroids, or liquorice root. The concern is electrolyte imbalance from prolonged laxative use or diarrhea, not a reason to inflate the base risk of ordinary short-term use.

09

Legal and regulatory status

U.S. OTC laxative status does not support nootropic claims9

United States context (as of 2026): current DailyMed OTC labels describe sennosides as a laxative for occasional constipation. This U.S. product-label context does not establish a global legal status or support cognitive, detox, weight-loss, or chronic daily-wellness claims.

10

Practical buying and quality notes

  • Compare site offers by form, package quantity, and listed unit price. Separately check the product label for sennosides per serving, package directions, and short-term-use limits; do not infer active dose from leaf grams, powder weight, or marketing words.9
  • A tea bag, raw leaf powder, pod product, and tablet standardized to sennosides can deliver very different exposures. Site price rows can compare form, package quantity, and listed units, but cannot rank active-dose value unless the corresponding product label discloses sennosides.8
11

FAQ

Is Senna a nootropic?

3

No. Senna is a stimulant laxative. It has constipation evidence, but no reliable human evidence for focus, memory, mood, or mental energy.

What should buyers check on a senna label?

8

Check whether the label discloses sennosides per serving, not just raw herb weight. When that amount is absent, price rows can compare the package but cannot establish an active-dose value comparison.

How fast does Senna work?

9

U.S. OTC labels commonly state that oral sennosides produce a bowel movement in 6-12 hours. That delayed laxative timing should not be reframed as an acute mental-performance effect.

Can Senna be used every day?

9

Not as an unsupervised wellness habit. A current U.S. OTC label says not to use laxative products for longer than one week unless directed by a doctor. That short self-use limit does not support a daily nootropic or wellness routine.

Why are detox and slimming teas a concern?

4

Senna is a stimulant laxative, so detox or slimming-tea marketing can hide the practical risks of cramping, diarrhea, dehydration, electrolyte disturbance, and misuse. Evaluate it as a laxative product, not as a cognitive supplement or everyday wellness aid.

12

References

  1. NCBI Taxonomy. Senna alexandrina, Taxonomy ID 72402. Accessed 2026-06-30.
  2. PubChem. Sennoside A, CID 73111. Accessed 2026-06-30.
  3. MedlinePlus. Senna: Drug Information. U.S. National Library of Medicine. Accessed 2026-06-30.
  4. LiverTox. Senna. NCBI Bookshelf. Accessed 2026-06-30.
  5. Morishita D, Tomita T, Mori S, et al. Senna Versus Magnesium Oxide for the Treatment of Chronic Constipation: A Randomized, Placebo-Controlled Trial. American Journal of Gastroenterology. 2021;116(1):152-161.
  6. Bharucha AE, Dorn SD, Lembo A, Pressman A. Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic Review. American Journal of Gastroenterology. 2021;116(6):1156-1181.
  7. Gordon M, MacDonald JK, Parker CE, Akobeng AK, Thomas AG. Osmotic and stimulant laxatives for the management of childhood constipation. Cochrane Database of Systematic Reviews. 2016.
  8. Chang L, Chey WD, Imdad A, et al. American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation. American Journal of Gastroenterology. 2023;118(6):936-954.
  9. DailyMed. SENNOSIDES capsule, liquid filled: OTC Drug Facts. U.S. National Library of Medicine. Updated 2025-12-22.
  10. European Medicines Agency. Sennae folium: herbal medicinal product. Summary for the public, EMA/697536/2018. Accessed 2026-08-18.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.